Ocular symptoms of multiple sclerosis
Article Sidebar
Published:
Mar 30, 2018
Keywords:
multiple sclerosis, MS ocular symptoms, retrobulbar optic neuritis
Main Article Content
Abstract
Multiple sclerosis (MS) is the main reason of disability among young people in well-developed countries. One of the first symptoms of the disease is retrobulbar optic nerve inflammation. It appers that there is also a lot of other ocular symptoms in MS. Some of this symptoms occurs a few years before the diagnosis. Authors review all of the ocular symptoms in MS.
Downloads
Download data is not yet available.
Article Details
How to Cite
1.
Glasner P, Serkies-Minuth E, Koberda M, Glasner L. Ocular symptoms of multiple sclerosis. Ophthatherapy [Internet]. 2018Mar.30 [cited 2024May7];5(1):10-5. Available from: https://www.journalsmededu.pl/index.php/ophthatherapy/article/view/966
Issue
Section
Articles
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Copyright: © Medical Education sp. z o.o. License allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
Address reprint requests to: Medical Education, Marcin Kuźma (marcin.kuzma@mededu.pl)
References
1. Kalincik T. Multiple Sclerosis Relapses: Epidemiology, Outcomes and Management. A Systematic Review. Neuroepidemiology. 2015; 44: 199-214.
2. Ascherio A, Munger KL. Environmental risk factors for multiple sclerosis. Part I: The role of infection. Ann Neurol. 2007; 61: 288-99.
3. Toussaint D, Perier O, Verstappen A et al. Clinicopathological study of the visual pathways, eyes, and cerebral hemispheres in 32 cases of disseminated sclerosis. J Clin Neuroophthalmol. 1983; 3(3): 211-20.
4. Ikuta F, Zimmerman HM. Distribution of plaques in seventy autopsy cases of multiple sclerosis in the united states. Neurology. 1976; 26(6 PT 2): 26-8.
5. Cendrowski W. Stwardnienie rozsiane. PZWL, Warszawa 1993: 9-12.
6. Stępień A. Neurologia, tom III. Medical Tribune Polska, Warszawa 2011: 183-95.
7. Selmaj K. Stwardnienie rozsiane – kryteria diagnostyczne i naturalny przebieg choroby. Polski Przegląd Neurologiczny. 2005; 3: 99-105.
8. Zakrzewska-Pniewska B. Podstawy diagnostyki i leczenia stwardnienia rozsianego. Via Medica, Gdańsk 2010: 38-40.
9. Andersen O. Natural history of multiple sclerosis. Saunders Elsevier 2008: 100-20.
10. Halilovic EA, Alimanovic I, Suljic E et al. Optic Neuritis a First Clinical Manifestations the Multiple Sclerosis. Mater Sociomed. 2014; 26(4): 246-8.
11. Balashow KE, Pal G, Rosenberg ML. Optic neuritis incidence is increased in spring months in patients with asymptomatic demyelinating lesions. Mult Scler. 2010; 16(2): 252-4.
12. Sobura-Ojeda A. Neuropatia demielinizacyjna nerwu wzrokowego. Przegląd Okulistyczny. 2015; 5(67): 1-2.
13. Kupersmith JM, Mandel G, Anderson S et al. Acute Optic Imaging of the Peripapillary RNFL in Optic Neuritis – Alterations in Birefringence and Retardance Properties. Invest Ophthalmol Vis Sci. 2008; 49: 5389.
14. Obuchowska I. Współczesne aspekty diagnostyki i leczenia stwardnienia rozsianego z uwzględnieniem roli lekarza okulisty. Zeszyt edukacyjny „Kompendium Okulistyki”. 2014; 2(10): 4-13.
15. Roodhooft JM. Ocular problems in early stages of multiple sclerosis. Bull Soc Belge Ophtalmol. 2009; 313: 65-8.
16. Beyer AM, Rosche B, Pleyer U et al. Stellenwert der Uveitis im Rahmen demyelinisierender Erkrankungen des Zentralnervensystems. Nervenarzt. 2007; 78: 1389-98.
17. Le Scanff J, Seve P, Renoux C et al. Uveitis associated with multiple sclerosis. Mult Scler. 2008; 14: 415-417.
18. Chen L, Gordon LK. Ocular manifestations of multiple sclerosis. Curr Opin Ophthalmol. 2005; 16: 315-20.
19. Cerovski B, Vidović T, Petriček I et al. Multiple sclerosis and neuro-ophthalmologic manifestations. Coll Antropol. 2005; 29(Suppl 1): 153-8.
20. Balcer LJ, Miller DH, Reingold SC et al. Vision and vision-related outcome measures in multiple sclerosis. Brain. 2015; 138(1): 11-27.
21. Cole SR, Beck RW, Moke PS et al. The National Eye Institute Visual Function Questionnaire: experience of the ONTT. Optic Neuritis Treatment Trial. Invest Ophthalmol Vis Sci. 2000; 41: 1017-21.
22. Sergott RC, Frohman E, Glanzman R et al. The role of optical coherence tomography in multiple sclerosis: expert panel consensus. J Neurol Sci. 2007; 263(1): 3-14.
23. Trip SA, Schlottmann PG, Jones SJ et al. Retinal nerve fiber layer axonal loss and visual dysfunction in optic neuritis. Ann Neurol. 2005; 58: 383-91.
24. Trip SA, Wheeler-Kingshott C, Jones SJ et al. Optic nerve diffusion tensor imaging in optic neuritis. Neuroimage. 2006; 30: 498-505.
25. Fisher JB, Jacobs DA, Markowitz CE et al. Relation of visual function to retinal nerve fiber layer thickness in multiple sclerosis. Ophthalmology. 2006; 113: 324-32.
26. Hickman SJ, Brex PA, Brierley CM et al. Detection of optic nerve atrophy following a single episode of unilateral optic neuritis by MRI using a fat-saturated short-echo fast FLAIR sequence. Neuroradiology. 2001; 43: 123-8.
27. Costello F, Coupland S, Hodge W et al. Quantifying axonal loss after optic neuritis with optical coherence tomography. Ann Neurol. 2006; 59: 963-9.
28. Pro MJ, Pons ME, Liebmann JM et al. Imaging of the optic disc and retinal nerve fiber layer in acute optic neuritis. J Neurol Sci. 2006; 250: 114-9.
29. Saidha S, Syc SB, Durbin MK et al. Visual dysfunction in multiple sclerosis correlates better with optical coherence tomography derived estimates of macular ganglion cell layer thickness than peripapillary retinal nerve fiber layer thickness. Mult Scler. 2011; 17(12): 1449-63.
30. Burkholder BM, Osborne B, Loguidice MJ et al. Macular volume determined by optical coherence tomography as a measure of neuronal loss in multiple sclerosis. Arch Neurol. 2009; 66: 1366-72.
31. Saidha S, Eckstein C, Ratchford JN. Optical coherence tomography as a marker of axonal damage in multiple sclerosis. CML – Multiple Sclerosis. 2010; 2: 33-43.
32. Papakostopoulos D, Fotiou F, Hart JC et al. The electroretinogram in multiple sclerosis and demyelinating optic neuritis. Electroencephalogr Clin Neurophysiol. 1989; 74: 1-10.
33. Saidha S, Syc SB, Ibrahim MA et al. Primary retinal pathology in multiple sclerosis as detected by optical coherence tomography. Brain. 2011; 134: 518-33.
2. Ascherio A, Munger KL. Environmental risk factors for multiple sclerosis. Part I: The role of infection. Ann Neurol. 2007; 61: 288-99.
3. Toussaint D, Perier O, Verstappen A et al. Clinicopathological study of the visual pathways, eyes, and cerebral hemispheres in 32 cases of disseminated sclerosis. J Clin Neuroophthalmol. 1983; 3(3): 211-20.
4. Ikuta F, Zimmerman HM. Distribution of plaques in seventy autopsy cases of multiple sclerosis in the united states. Neurology. 1976; 26(6 PT 2): 26-8.
5. Cendrowski W. Stwardnienie rozsiane. PZWL, Warszawa 1993: 9-12.
6. Stępień A. Neurologia, tom III. Medical Tribune Polska, Warszawa 2011: 183-95.
7. Selmaj K. Stwardnienie rozsiane – kryteria diagnostyczne i naturalny przebieg choroby. Polski Przegląd Neurologiczny. 2005; 3: 99-105.
8. Zakrzewska-Pniewska B. Podstawy diagnostyki i leczenia stwardnienia rozsianego. Via Medica, Gdańsk 2010: 38-40.
9. Andersen O. Natural history of multiple sclerosis. Saunders Elsevier 2008: 100-20.
10. Halilovic EA, Alimanovic I, Suljic E et al. Optic Neuritis a First Clinical Manifestations the Multiple Sclerosis. Mater Sociomed. 2014; 26(4): 246-8.
11. Balashow KE, Pal G, Rosenberg ML. Optic neuritis incidence is increased in spring months in patients with asymptomatic demyelinating lesions. Mult Scler. 2010; 16(2): 252-4.
12. Sobura-Ojeda A. Neuropatia demielinizacyjna nerwu wzrokowego. Przegląd Okulistyczny. 2015; 5(67): 1-2.
13. Kupersmith JM, Mandel G, Anderson S et al. Acute Optic Imaging of the Peripapillary RNFL in Optic Neuritis – Alterations in Birefringence and Retardance Properties. Invest Ophthalmol Vis Sci. 2008; 49: 5389.
14. Obuchowska I. Współczesne aspekty diagnostyki i leczenia stwardnienia rozsianego z uwzględnieniem roli lekarza okulisty. Zeszyt edukacyjny „Kompendium Okulistyki”. 2014; 2(10): 4-13.
15. Roodhooft JM. Ocular problems in early stages of multiple sclerosis. Bull Soc Belge Ophtalmol. 2009; 313: 65-8.
16. Beyer AM, Rosche B, Pleyer U et al. Stellenwert der Uveitis im Rahmen demyelinisierender Erkrankungen des Zentralnervensystems. Nervenarzt. 2007; 78: 1389-98.
17. Le Scanff J, Seve P, Renoux C et al. Uveitis associated with multiple sclerosis. Mult Scler. 2008; 14: 415-417.
18. Chen L, Gordon LK. Ocular manifestations of multiple sclerosis. Curr Opin Ophthalmol. 2005; 16: 315-20.
19. Cerovski B, Vidović T, Petriček I et al. Multiple sclerosis and neuro-ophthalmologic manifestations. Coll Antropol. 2005; 29(Suppl 1): 153-8.
20. Balcer LJ, Miller DH, Reingold SC et al. Vision and vision-related outcome measures in multiple sclerosis. Brain. 2015; 138(1): 11-27.
21. Cole SR, Beck RW, Moke PS et al. The National Eye Institute Visual Function Questionnaire: experience of the ONTT. Optic Neuritis Treatment Trial. Invest Ophthalmol Vis Sci. 2000; 41: 1017-21.
22. Sergott RC, Frohman E, Glanzman R et al. The role of optical coherence tomography in multiple sclerosis: expert panel consensus. J Neurol Sci. 2007; 263(1): 3-14.
23. Trip SA, Schlottmann PG, Jones SJ et al. Retinal nerve fiber layer axonal loss and visual dysfunction in optic neuritis. Ann Neurol. 2005; 58: 383-91.
24. Trip SA, Wheeler-Kingshott C, Jones SJ et al. Optic nerve diffusion tensor imaging in optic neuritis. Neuroimage. 2006; 30: 498-505.
25. Fisher JB, Jacobs DA, Markowitz CE et al. Relation of visual function to retinal nerve fiber layer thickness in multiple sclerosis. Ophthalmology. 2006; 113: 324-32.
26. Hickman SJ, Brex PA, Brierley CM et al. Detection of optic nerve atrophy following a single episode of unilateral optic neuritis by MRI using a fat-saturated short-echo fast FLAIR sequence. Neuroradiology. 2001; 43: 123-8.
27. Costello F, Coupland S, Hodge W et al. Quantifying axonal loss after optic neuritis with optical coherence tomography. Ann Neurol. 2006; 59: 963-9.
28. Pro MJ, Pons ME, Liebmann JM et al. Imaging of the optic disc and retinal nerve fiber layer in acute optic neuritis. J Neurol Sci. 2006; 250: 114-9.
29. Saidha S, Syc SB, Durbin MK et al. Visual dysfunction in multiple sclerosis correlates better with optical coherence tomography derived estimates of macular ganglion cell layer thickness than peripapillary retinal nerve fiber layer thickness. Mult Scler. 2011; 17(12): 1449-63.
30. Burkholder BM, Osborne B, Loguidice MJ et al. Macular volume determined by optical coherence tomography as a measure of neuronal loss in multiple sclerosis. Arch Neurol. 2009; 66: 1366-72.
31. Saidha S, Eckstein C, Ratchford JN. Optical coherence tomography as a marker of axonal damage in multiple sclerosis. CML – Multiple Sclerosis. 2010; 2: 33-43.
32. Papakostopoulos D, Fotiou F, Hart JC et al. The electroretinogram in multiple sclerosis and demyelinating optic neuritis. Electroencephalogr Clin Neurophysiol. 1989; 74: 1-10.
33. Saidha S, Syc SB, Ibrahim MA et al. Primary retinal pathology in multiple sclerosis as detected by optical coherence tomography. Brain. 2011; 134: 518-33.